logo-loader
RNS
viewConvaTec Group PLC

Director/PDMR Shareholding

/**/ link{ color: blue }visited{ color: #954F72 } .ab{size:595.3pt 841.9pt;margin:72.0pt 72.0pt 72.0pt 72.0pt;}div.ab{}p.r,li.r,div.r{margin-right:0cm;margin-left:0cm;font-size:12.0pt;font-family:"Times New Roman","serif";}span.be{font-size:10.5pt;font-family:"Arial","sans-serif"}p.bg{margin-right:0cm;margin-left:0cm;font-size:12.0pt;font-family:"Times New Roman","serif";font-weight: bold; text-align: center}span.bd{font-size: 10.5pt;font-family:"Arial","sans-serif"}p.bh{margin-top:0cm;margin-right:0cm;margin-bottom:8.0pt;margin-left:0cm;line-height:107%;font-size:11.0pt;font-family:"Calibri","sans-serif";margin-top:11.55pt;margin-right:0cm;margin-bottom: 11.55pt;margin-left:0cm;text-align:justify;text-justify:inter-ideograph; line-height:normal}p.bi{margin-right:0cm;margin-left:0cm;font-size:12.0pt;font-family:"Times New Roman","serif";text-align: center}table.bj{margin-left:-7.35pt;border:solid windowtext 1.0pt}td.ax{width:22.8pt;border:solid windowtext 1.0pt; padding:0cm 0cm 0cm 0cm} p.bk{margin-top:0cm;margin-right:0cm;margin-bottom:8.0pt;margin-left:0cm;line-height:107%;font-size:11.0pt;font-family:"Calibri","sans-serif";font-weight: bold; margin-left: 8.5pt}span.az{font-size:10.5pt; line-height:107%;font-family:"Arial","sans-serif"}td.av{width:437.4pt;border:solid windowtext 1.0pt; padding:0cm 0cm 0cm 0cm}p.bl{margin-top:0cm;margin-right:0cm;margin-bottom:8.0pt;margin-left:0cm;line-height:107%;font-size:11.0pt;font-family:"Calibri","sans-serif";font-weight: bold; margin-left: 9.05pt}td.at{width:171.25pt;border:solid windowtext 1.0pt; padding:0cm 0cm 0cm 0cm}p.bm{margin-top:0cm;margin-right:0cm;margin-bottom:8.0pt;margin-left:0cm;line-height:107%;font-size:11.0pt;font-family:"Calibri","sans-serif";font-weight: bold; margin-left: 8.85pt}td.ar{border:solid windowtext 1.0pt;padding:0cm 0cm 0cm 0cm}p.bn{margin-top:0cm;margin-right:0cm;margin-bottom:8.0pt;margin-left:0cm;line-height:107%;font-size:11.0pt;font-family:"Calibri","sans-serif";text-indent:6.35pt}p.bo{margin-top:0cm;margin-right:0cm;margin-bottom:8.0pt;margin-left:0cm;line-height:107%;font-size:11.0pt;font-family:"Calibri","sans-serif";font-weight: bold; line-height: normal; margin-bottom: 11.55pt; margin-left: 8.85pt; margin-right: 0cm; margin-top: 11.55pt}p.bp{margin-top:0cm;margin-right:0cm;margin-bottom:8.0pt;margin-left:0cm;line-height:107%;font-size:11.0pt;font-family:"Calibri","sans-serif";margin-left:6.45pt;text-indent:.45pt} span.ap{font-size:10.5pt;line-height:107%;font-family:"Arial","sans-serif"}td.an{width:165.8pt;border:solid windowtext 1.0pt; padding:0cm 0cm 0cm 0cm}td.am{width:101.5pt;border:solid windowtext 1.0pt; padding:0cm 0cm 0cm 0cm}p.bq{margin-top:0cm;margin-right:0cm;margin-bottom:8.0pt;margin-left:0cm;line-height:107%;font-size:11.0pt;font-family:"Calibri","sans-serif";margin-left:6.45pt}td.aj{width:22.8pt;border:solid windowtext 1.0pt;padding:0cm 0cm 0cm 0cm}p.br{margin-top:0cm;margin-right:0cm;margin-bottom:8.0pt;margin-left:0cm;line-height:107%;font-size:11.0pt;font-family:"Calibri","sans-serif";margin-left:8.5pt}td.ah{width:171.25pt;border:solid windowtext 1.0pt;padding: 0cm 0cm 0cm 0cm}p.a,li.a,div.a{margin-top:0cm;margin-right:0cm;margin-bottom:8.0pt;margin-left:0cm;line-height:107%;font-size:11.0pt;font-family:"Calibri","sans-serif";}span.ai{font-size:10.5pt;line-height:107%;font-family: "Arial","sans-serif"}td.ag{width:165.8pt;border:solid windowtext 1.0pt;padding: 0cm 0cm 0cm 0cm} td.af{width:61.9pt;border:solid windowtext 1.0pt;padding:0cm 0cm 0cm 0cm}p.bs{margin-right:0cm;margin-left:0cm;font-size:12.0pt;font-family:"Times New Roman","serif";text-align:justify;text-justify:inter-ideograph}span.ad{font-size:10.5pt;font-family: "Arial","sans-serif"} /**/
RNS Number : 6105Q
ConvaTec Group PLC
21 October 2019
 

21 October 2019

ConvaTec Group Plc
("ConvaTec" or "the Company")
Director/PDMR Shareholding

The Company has been notified of the following transaction by a Person Discharging Managerial Responsibility ("PDMR") in ordinary shares of 10 pence each in the share capital of the Company ("Shares").

On 17 October 2019, Mr Rick Anderson, Non-Executive Director, acquired 613 Shares at £1.7445 per share as part of the Scrip Dividend Scheme. Mr Anderson's resulting shareholding is 207,268 Shares.

The attached notification, made in accordance with the requirements of the EU Market Abuse Regulation, gives further detail.

NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Mr Rick Anderson

2

Reason for the notification

a)

Position/Status

Non-Executive Director

b)

Initial notification/Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

ConvaTec Group Plc

b)

LEI

213800LS272L4FIDOH92

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary shares of 10p each in ConvaTec Group Plc ("Shares")

 

GB00BD3VFW73

b)

Nature of the transaction

Acquisition of Shares via Scrip Dividend Scheme

c)

Price(s) and volume(s)

Price(s)

£1.7445

Volume(s)

613

d)

Aggregated information

- Aggregated volume 

- Price

 

613

£1,069.38

e)

Date of the transaction

17 October 2019

f)

Place of the transaction

Outside a trading venue

 

Enquiries

Media

Analysts and Investors

John Crosse, VP Investor Relations, ConvaTec                      +44 (0)7500 141 435

Mark Reynolds, Director Investor Relations, ConvaTec           +44 (0)7551 036 625

[email protected]

Buchanan                                                                                  +44 (0)207 466 5000

ConvaTec Group Plc's LEI code is 213800LS272L4FIDOH92                                               

About ConvaTec

ConvaTec is a global medical products and technologies company focused on therapies for the management of chronic conditions, with leading market positions in advanced wound care, ostomy care, continence and critical care, and infusion devices. ConvaTec's products provide a range of clinical and economic benefits including infection prevention, protection of at-risk skin, improved patient outcomes and reduced total cost of care. To learn more about ConvaTec, please visit www.convatecgroup.com where a copy of this announcement can also be found.

 

                                                                        END


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
DSHLLFVEIALLFIA

Quick facts: ConvaTec Group PLC

Price: 212.8

Market: LSE
Market Cap: £4.22 billion
Follow

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE